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The amphibian model Xenopus, has been used extensively over the past century to study multiple aspects
of cell and developmental biology. Xenopus offers advantages of a non-mammalian system, including
high fecundity, external development, and simple housing requirements, with additional advantages of
large embryos, highly conserved developmental processes, and close evolutionary relationship to higher
vertebrates. There are two main species of Xenopus used in biomedical research, Xenopus laevis and
Xenopus tropicalis; the common perception is that both species are excellent models for embryological
and cell biological studies, but only Xenopus tropicalis is useful as a genetic model. The recent completion
of the Xenopus laevis genome sequence combined with implementation of genome editing tools, such as
TALENs (transcription activator-like effector nucleases) and CRISPR-Cas (clustered regularly interspaced
short palindromic repeats-CRISPR associated nucleases), greatly facilitates the use of both Xenopus laevis
and Xenopus tropicalis for understanding gene function in development and disease. In this paper, we
review recent advances made in Xenopus laevis and Xenopus tropicalis with TALENs and CRISPR-Cas and
discuss the various approaches that have been used to generate knockout and knock-in animals in both
species. These advances show that both Xenopus species are useful for genetic approaches and in par-
ticular counters the notion that Xenopus laevis is not amenable to genetic manipulations.
& 2016 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
With the advent of customizable genome editing technologies,
such as TALENs (transcription activator-like effector nucleases)
and CRISPR-Cas (clustered regularly interspaced short palindromic
repeats-CRISPR associated), it is now possible to model human
genetic disorders in any animal or cellular system, including pre-
viously non-genetic models such as Xenopus laevis (Harrison et al.,
2014; Peng et al., 2014). These advances provide researchers with a
broader range of animal models, allowing them to choose the most
experimentally tractable and biologically relevant system in which
to test the function of speciﬁc disease-associated genes. In this
review, we discuss the application of new genome editing tech-
nologies in both Xenopus laevis and Xenopus tropicalis, and how
these advances will enhance our understanding of the molecular
mechanisms underlying human disease.
Xenopus has many experimental advantages that make it aInc. This is an open access article u
on),well-suited model for the study and functional characterization of
candidate genes involved in human disease. The Xenopus tropicalis
genome contains orthologues of 79% of the identiﬁed human
disease genes (Hellsten et al., 2010; Khokha, 2012). Both Xenopus
species have been used to study all aspects of vertebrate embry-
ology, such as gastrulation, axis development and organ formation,
dating back to the nineteenth century. These studies have pro-
vided insight into highly conserved members of major signal
transduction pathways, for instance, BMPs and Wnts (Bier and De
Robertis, 2015; Hikasa and Sokol, 2013). Notably, Sir John Gurdon
(2012) and Professor Tim Hunt (2001) were awarded Nobel prizes
for their ground-breaking research performed in Xenopus laevis
(Gurdon, 2013; Hunt, 2002). The ease with which X. laevis and X.
tropicalis embryos can be cultured in simple buffers and raised to
adulthood enables the use of these models in most laboratory
settings. Due to the large number of progeny that can be obtained
from a single mating, Xenopus provides ample embryonic tissue
for a wide range of experimental assays, including phenotypic
analyses, RNAseq, ChIPseq and proteomics (Chung et al., 2014;
Onjiko et al., 2015; Peshkin et al., 2015; Wühr et al., 2014; Yanai
et al., 2011). Because of their relatively large size and ability tonder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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studies focused on manipulating gene function via microinjection
of morpholinos, DNA constructs, translated capped RNA, and
protein. Overexpression or misexpression of wild-type or domi-
nant negative proteins were facilitated by simple and efﬁcient
transgenesis approaches, by a variety of means, including restric-
tion enzyme mediated integration (REMI), I-SceI meganuclease or
transposon mediated insertion of constructs into the Xenopus
genome, and are reviewed elsewhere (Buchholz, 2012; Ishibashi
et al., 2012b, 2012c; Kelley et al., 2012). In addition, the ability to
fate map cell lineages from various embryonic blastomeres and
tissue regions in Xenopus has greatly enhanced our understanding
of the developmental, genetic, and evolutionary origin of adult
structures and organs, which is essential for determining disease
etiology (Chalmers and Slack, 2000; Lane and Sheets, 2006). These
experimental advantages, together with their rapid external de-
velopment, detailed temporal staging atlas, and relative transpar-
ency facilitate gene function assessment, making both Xenopus
species versatile model systems for disease research and pheno-
typic drug screening (Harland and Grainger, 2011; Schmitt et al.,
2014).
Among aquatic vertebrate model animals, Xenopus excels by
having comparable organ development and morphology to
mammalian systems, but with the added beneﬁt of being able to
regenerate adult tissues, such as optic nerve, lens, spinal cord and
limb tissue (Blitz et al., 2006; Muñoz et al., 2015; Slack et al.,
2008). Xenopus animals and oocytes are used extensively to un-
derstand normal organ function and disease in humans (Labonne
and Zorn, 2015), including cardiac congenital heart disorders and
heterotaxy (Boskovski et al., 2013; Duncan and Khokha, 2016;
Fakhro et al., 2011; Kaltenbrun et al., 2011; Langdon et al., 2012;
2007), gastrointestinal and pancreatic diseases (Kofent and Spag-
noli, 2016; Pearl et al., 2009; 2011; Salanga and Horb, 2015;
Womble et al., 2016), endocrine functions and disorders (Buch-
holz, 2015), kidney disease (Lienkamp, 2016), lung development
(Rankin et al., 2011; 2015; Wallmeier et al., 2014), cancer (Chernet
and Levin, 2013; Cross and Powers, 2009; Hardwick and Philpott,
2015; Haynes-Gilmore et al., 2014; Van Nieuwenhuysen et al.,
2015; Wylie et al., 2015), ciliopathies (Kim et al., 2010; Klos
Dehring et al., 2013; Ma et al., 2014), orofacial defects (Dickinson,
2016), and neurodevelopmental disorders (Erdogan et al., 2016;
Pratt and Khakhalin, 2013). Looking forward, Xenopus is poised to
take advantage of the new developments in genomics and genome
engineering to better understand the molecular mechanisms un-
derlying human disease (Harland and Grainger, 2011; Labonne and
Zorn, 2015).
While genetics is available in ﬁsh and mice as surrogate sys-
tems for understanding human biology and disease, the develop-
ment of Xenopus genetics offers a number of advantages not found
in other organisms. Unlike the mouse, Xenopus embryos can be
produced in large numbers and are accessible throughout their
development, simplifying phenotypic screening at embryonic
stages. Xenopus shares surprising similarities with humans both at
the level of its genome and its anatomy. The frog genome has long
regions in which genes exhibit remarkably similar syntenic re-
lationships to those found in the human genome (Amodeo et al.,
2015; Blitz, 2012; Blitz et al., 2013; Bodart and Duesbery, 2006;
Davidson, 1973; Grant et al., 2015; Hellsten et al., 2010; Paranjpe
et al., 2013; Roe et al., 1985; Showell et al., 2011; Uno et al., 2013).
In many cases, orthologous genes are found in equivalent regions
of the human and frog genomes, in which the order of genes along
the chromosomes is largely conserved. In fact, the vast majority of
the breaks in synteny are from single exon genes identiﬁed by
automated ORF prediction algorithms but not supported by EST
evidence (Blitz, 2012; Geach et al., 2012; Krylov and Tlapakova,
2015; Macha et al., 2012; Pollet and Mazabraud, 2006; Showelland Conlon, 2007). Therefore, shared synteny may be even more
prevalent than is currently thought. Moreover, while it is well
established that mice are genetically tractable, mice are difﬁcult
for live imaging or biochemistry. Thus by combining genome
editing with the advantages of both Xenopus species, researchers
have the unique opportunity to integrate systems level genomic
and proteomic analyses with quantitative live imaging of cell be-
haviors in genetically approachable vertebrate model systems.2. Xenopus laevis versus Xenopus tropicalis
Currently, there are two main Xenopus species used in biome-
dical research, Xenopus laevis and Xenopus tropicalis. Historically, X.
laevis has been the predominant Xenopus species studied since the
1950s due to its large size, ability to ovulate year round, and ex-
perimental robustness. These animals can be grown between 18
and 23 °C in basic salt solutions, in relatively simple aquatic
housing. They are the animal of choice for many biomedical re-
searchers, including those using the Xenopus oocyte model to
study ion channel electrophysiology, cell protein biochemistry, cell
cycle biology, and cytoskeletal dynamics, as well as those em-
ploying the Xenopus embryo model to study development (Du-
baissi and Papalopulu, 2011; Kay and Peng, 1991; Maksaev and
Haswell, 2015; Mitchison et al., 2015). One of the drawbacks often
cited with X. laevis is its poor genetic tractability, which was
thought due to its allotetraploid genome and relatively long gen-
eration time of 10–12 months; thus, most researchers have had
little interest in the genetic background of X. laevis and have
purchased outbred genetically heterogeneous frogs from com-
mercial vendors. However, in the past 5 years, an inbred strain of
X. laevis, known as the J strain, has become available through the
National Xenopus Resource and the European Xenopus Resource
Centre (Gantress et al., 2003; Pearl et al., 2012; Tochinai and Ka-
tagiri, 1975), and the J strain draft genome sequence (Session et al.,
2016) is now available on Xenbase (http://www.xenbase.org;
X. laevis Genome Project Consortium). This newly sequenced
strain will allow for more genetic analyses in X. laevis and when
combined with recent advances in genome editing technologies,
has made it possible for essentially any lab to make mutants
through targeted reverse genetics. In more recent years, X. tropi-
calis has become increasingly used as a genetic model because it
offers the same embryological beneﬁts as X. laevis, but has a
shorter generation time of 5–7 months, a smaller size, and a di-
ploid genome. However, water conditions are slightly different for
X. laevis and X. tropicalis, and hence they require separate housing
systems, making it more expensive for individual labs to maintain
colonies of both species. In light of these considerations, most
researchers focus on one model species, but both species offer
unique advantages that are being exploited by the wider Xenopus
community.
Inbred J strain X. laevis and Nigerian X. tropicalis frogs can be
purchased from the National Xenopus Resource (NXR) in the US or
the European Xenopus Resource Center (EXRC) in the UK. These
resource centers were established in the past 10 years to serve as
the main stock centers for the Xenopus community for inbred,
transgenic and mutant lines (Pearl et al., 2012). Their recent ad-
vances in husbandry have optimized X. laevis maintenance, and it
is now possible to perform in vitro fertilization from males as
young as 4 months old, which has decreased the time required to
raise lines of X. laevis (Horb, M.E. unpublished). In addition, these
stock centers have worked to improve the cryopreservation of X.
laevis and X. tropicalis sperm, allowing subsequent matings and
the sharing of colony lines among the community. These im-
provements bring Xenopus more in line with other model systems
and enable the proper maintenance and distribution of different
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Complete sequencing of both X. laevis and X. tropicalis genomes
has revealed larger regions of synteny, and presumably the sharing
of a longer common evolutionary history, with humans than those
of other popular model systems (Hellsten et al., 2010). X. tropicalis
is the only diploid species in the Xenopus genus, and its genome is
comprised of twenty chromosomes, whereas X. laevis is an allo-
tetraploid species that arose from the interspeciﬁc hybridization of
two diploid species, and its genome consists of 36 chromosomes
(Matsuda et al., 2015; Uno et al., 2013). There are nine pairs of
homeologous chromosomes in X. laevis, which are named Long
(L) and Short (S) that functionally segregate as two separate di-
ploid genomes (Matsuda et al., 2015; Tymowska, 1991). A new
nomenclature for the X. laevis chromosomes was recently estab-
lished based on their phylogenetic relationship and length, such
that the homeologous chromosomes are named Xla1L and Xla1S
through Xla9L and Xla9S (Matsuda et al., 2015). The ﬁrst eight
pairs of X. laevis chromosomes correspond to those of X. tropicalis,
whereas the ninth chromosome pair contains fusions of chromo-
somes 9 and 10 from X. tropicalis and thus, they are also named
Xla9_10L and Xla9_10S to emphasize their phylogenetic relation-
ship. As the name implies, S chromosomes are shorter than L
chromosomes, and this is due to loss of genes on the S chromo-
somes; it has been postulated that at least 17%, but perhaps as
much as 50%, of the genes in X. laevis remain in a diploid/singleton
state due to loss of genes on the S chromosomes (Hellsten et al.,
2007; Uno et al., 2013), making the generation of mutants rela-
tively simple for such target genes. These genome annotation
advances, together with the recently completed Xenopus ORFeome
project (Grant et al., 2015) that identiﬁed orthologues of 2724
human genes associated with an Online Mendelian Inheritance in
Man (OMIM)-recognized disease, makes X. laevis an ideal model to
study vertebrate development and human disorders.
All of the beneﬁts discussed above demonstrate that both Xe-
nopus species are excellent model systems that will be greatly
enhanced with emerging genome-editing methodology. These
revolutionizing technologies will allow for the rapid creation of
mutant frogs to model human diseases, providing an abundant
source of material for functional studies. Utilizing genome editing
methods in Xenopus laevis and Xenopus tropicalis will provide a
cost effective platform to rapidly identify, validate, and char-
acterize genes involved in human diseases, which will ultimately
provide more detailed mechanistic insight to guide new ther-
apeutic strategies. Below, we describe the use of TALENs and
CRISPR-Cas based methods in Xenopus, and highlight some of the
emerging applications of these methods to understand human
diseases.3. Genome editing tools in Xenopus
In the past few years numerous methods have been generated
to efﬁciently edit the genomes of almost any cell type or organism,
including the amphibian models Xenopus laevis and tropicalis,
through the use of Zinc Finger Nucleases (ZFNs), Transcription
Activator-Like Effector Nucleases (TALENs) and Clustered Regularly
Interspaced Short Palindromic Repeats (CRISPR-Cas) nuclease
systems (Harrison et al., 2014; Peng et al., 2014). The nucleases are
targeted to a speciﬁc region of interest in the genome through the
microinjection of sequence-speciﬁc RNA constructs, and induce
double/single-stranded breaks in the DNA sequence. Upon re-
cognizing this damage, the cell uses non-homologous end joining
(NHEJ) or homology-directed repair (HDR) to repair the break.
NHEJ produces random insertions or deletions (indels) into the
target site, thereby causing potential DNA coding frame shifts and
altered protein translation. HDR, on the other hand, uses atemplate sequence to repair the broken DNA strands; this enables
the insertion of exogenous DNA sequences, such as ﬂuorescent
reporter transgenes to track gene expression and cell lineage, or
point mutations mimicking known human single nucleotide
polymorphisms (SNP) associated with a disease trait. As both TA-
LENs and CRISPR-Cas systems have proven to be more versatile
than ZFNs, we will focus on these more recently described gene-
editing methods that have revolutionized basic biology as well as
biomedical and other translational research.
3.1. TALENs in Xenopus
Originally identiﬁed in the plant pathogen Xanthomonas, TALE
proteins are transcriptional activators that speciﬁcally bind and
regulate plant gene expression upon infection (Joung and Sander,
2013; Kim and Kim, 2014). The TALE structure comprises a central
domain harboring speciﬁc repeating units of 33–35 amino acids
that target individual DNA bases (Bogdanove and Voytas, 2011).
These repeat variable di-residue (RVD) domains enable TALE
proteins to target almost any genomic region of interest. Site-
speciﬁc TALE proteins can be tethered to endonucleases to modify
genome sequence, or to transcriptional effector proteins, such as
VP16 and KRAB, to regulate gene activity in most eukaryotic or-
ganisms tested to date. To induce DNA breaks and modify genome
sequences, two TALEN arms are required to recognize and bind the
DNA sequence with a small 15–25 base spacer region in between.
This spacer allows the dimerization of the tethered Fok1 en-
donuclease catalytic domains, thereby enabling its enzymatic
function. Cloning individual TALENs is a multi-day process that
involves piecing together individual RVDs to create custom repeat
arrays targeted to a speciﬁc DNA sequence (Cermak et al., 2011).
The ﬁrst use of TALEN-induced mutations in Xenopus were
performed in X. tropicalis, demonstrating efﬁcient somatic and
germline mutagenesis (Ishibashi et al., 2012a; Lei et al., 2012). The
initial study targeted eight Xenopus genes involved in human
disease, and showed that TALENs induced mutations in F0 em-
bryos with a high efﬁciency at all eight loci (Lei et al., 2012). In
particular, they demonstrated that injection of TALENs targeting
the pancreatic transcription factor ptf1a resulted in pancreatic
agenesis in F0 tadpoles, mimicking the phenotype seen in humans
and conﬁrming previous morpholino knockdown phenotypes ob-
served in Xenopus (Afelik et al., 2006; Jarikji et al., 2007; Sellick
et al., 2004), but with efﬁcient germline transmission of mutations.
In addition, they showed that TALEN mutagenesis is more efﬁcient
and less toxic when compared directly to ZFNs, with no detectable
off-target effects (Lei et al., 2012). Another study by the Chen lab
showed that TALEN-mediated disruption of the n-myc down-
stream regulated 1 (ndgr1) gene in X. tropicalis displayed a similar
phenotype to that observed using morpholino knockdown of the
gene in X. laevis (Zhang et al., 2013). More recently, a compre-
hensive study by the Grainger lab demonstrated that X. tropicalis is
a useful model for understanding the developmental basis of hu-
man eye disorders. They performed an extensive characterization
of different TALEN-induced mutations in the pax6 gene and
identiﬁed several different phenotypes in both F0 and F1 frogs
(Nakayama et al., 2015). This group found that partial loss of
function of pax6 in F1 animals resulted in froglets with an un-
derdeveloped iris, a phenotype similar to that observed in human
aniridia. Collectively, these initial studies demonstrated that TA-
LEN-mediated genome editing works efﬁciently in F0 X. tropicalis,
and that these mutations are transmitted through the germline.
Xenopus not only provides a platform for the study of genes
involved in congenital malformations, but also for the study of
genes involved in developmental processes and diseases at later
stages. Recent studies by the Shi and Buchholz labs demonstrated
that TALEN-mediated genome editing is an effective method to
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tamorphosis in F0 X. tropicalis tadpoles, speciﬁcally in thyroid
hormone receptor, alpha (thra) gene (Choi et al., 2015; Wen et al.,
2015; Wen and Shi, 2015). Choi et al. showed that F0 phenotype
analysis and germline transmission of the TALEN-induced muta-
tions are facilitated by injection into one cell of two-cell embryos.
The Vleminckx lab used TALENs to create mutations in the X.
tropicalis tumor suppressor gene adenomatous polyposis coli (apc),
which is implicated as the initiating mutation in many colorectal
cancers, including familial adenomatous polyposis (FAP) syndrome
(Van Nieuwenhuysen et al., 2015). These studies demonstrated F0
tadpoles derived from embryos injected with apc-speciﬁc TALENs
develop intestinal hyperplasia and other neoplasms commonly
observed in FAP patients within 6 weeks providing a useful model
for the rapid testing of chemical compounds to treat FAP. These
results demonstrate that it is possible to utilize the mosaic nature
of TALEN-induced mutagenesis for studying advanced develop-
mental events as well as tumorigenesis in Xenopus tadpoles.
3.2. Circumventing embryonic lethality in F0 animals
One of the potential problems in generating mutant Xenopus
lines using TALENs is that, in some instances, the mutations result
in embryonic lethality, thus limiting analysis to the F0 generation.
Ideally, the best way to overcome this issue would be to induce
mutations only in germ cells and not in somatic tissue. In Xenopus,
there are two methods used to create such germ cell-speciﬁc
mutants. The ﬁrst is to limit the translation of injected mRNA to
germ cells. Several maternal mRNAs have speciﬁc germ cell re-
stricted translation due to the 3′UTR region, such as the gene
ddx25 (Kataoka et al., 2006). Recent work from the Yaoita lab
showed that the ddx25 3′UTR is sufﬁcient for largely restricting
translation of TALEN-injected mRNAs to the germ cells (Nakajima
and Yaoita, 2015a). They further demonstrated that bi-allelic TA-
LEN-induced mutations are present in the F0 adult germ cells and
transmitted to the F1 generation, with limited mutations found in
other organs, thus deﬁning a method for creating germ cell-spe-
ciﬁc mutants using TALENs. Another method to produce germ cell-
speciﬁc mutations is to transplant primordial germ cells from a
mutant embryo into a wild-type host embryo. In Xenopus, this can
be done by transplanting a portion of the vegetal hemisphere,
which contains the germ plasm of the early developing embryo, at
the blastula stage (Yang et al., 2015). Recent work from the Cho lab
showed that this method works well in X. tropicalis to produce F0
adults that are wild-type in the soma, but contain bi-allelic mu-
tations in the germ cells (Blitz and Cho personal communication);
adults produced using this method can be mated to create F1 null
progeny. These two methods will help speed up the process of
analyzing null mutations and allow for more detailed studies of
mutations that are embryonic lethal. In addition, because Xenopus
have long life spans (over 10 years), the mutant adults can be used
for many years.
Although inducing mutations in both homeologs in the allo-
tetraploid X. laevis is, in principal, more difﬁcult to achieve, several
recent studies have revealed that it is possible to generate highly
efﬁcient gene knockouts in both homeologs in X. laevis. The
complication with X. laevis is that, if the alloalleles are thought to
be functionally redundant, mutations must be induced in both
homeologs on the S and L chromosomes. The ﬁrst reports of the
effectiveness of TALENs in X. laevis showed that a single TALEN
pair can be designed to target both homeologous genes, and they
revealed that mutations can be detected as early as the morula
stage of development (Sakane et al., 2013; Suzuki et al., 2013).
Because sequence differences do exist between the alloalleles, it is
also possible to design TALENs to target only one of the home-
ologous genes. In one study, injection of two different pairs ofTALENs, targeting each alloallele, into X. laevis embryos was found
to induce mutations in each homeologous gene (Nakade et al.,
2015). This study also demonstrated mutation of the individual
homeolog was not possible when the speciﬁc TALEN binding site
contained three mismatches to the endogenous sequence, high-
lighting the speciﬁcity of TALENs. Although these results showed
that it is possible to induce mutations in both alloalleles in X.
laevis, either separately or together, they also revealed that gen-
erating mutations in all four copies is not efﬁcient enough to
produce null F0 frogs due to the delay in initiating NHEJ in all cells.
Using a well-established Xenopus method called the oocyte-
host transfer technique, which was developed to knockdown
maternal transcripts, it is possible to induce mutations more ra-
pidly and efﬁciently than traditional embryo injections. Therefore,
using the oocyte-host transfer (OHT) technique combined with
genome editing will result in less mosaic F0 animals and more
efﬁcient germ line transmission of mutations (Fig. 1). In this
method, heterologous mRNAs are injected into Xenopus oocytes,
which are then cultured in vitro for 24–48 h, transferred into an
ovulating host female, and the laid eggs are subsequently fertilized
in vitro (Olson et al., 2012). Using this technique, the Yaoita lab
demonstrated that TALEN-mediated gene disruption is more efﬁ-
cient when injected into oocytes rather than embryos (Nakajima
and Yaoita, 2015b). Similarly, we found that a single TALEN pair
targeting both tyrosinase homeologs was able to generate almost
complete albinism in F0 animals when injected into X. laevis oo-
cytes (Ratzan et al., 2016); conversely, injection of these same
TALENs into embryos resulted in mosaic F0 frogs, with only small
patches of albinism (Fig. 1). Furthermore, the F0 oocyte-injected
adults laid albino eggs, and when mated with sibling males, pro-
duced 50–75% albinism in the F1 generation; in contrast, all off-
spring from sibling-mated F0 embryo-injected adults failed to
produce albino offspring, and very few mutations were recovered
in the F1 generation (Ratzan et al., 2016).
An alternative method to induce genetic mutations prior to
fertilization has recently been published by the Gurdon lab
(Miyamoto et al., 2015a, 2015b, 2013). To forego oocyte transfer
back into a host female and therefore abolish further surgery, they
used intracytoplasmic sperm injection (Miyamoto et al., 2015a). In
this procedure, X. laevis oocytes are extracted, enzymatically de-
folliculated and subsequently injected with TALEN mRNA (Fig. 1);
these late stage oocytes are then matured by addition of proges-
terone and subsequently injected with a sperm mixture (to negate
the need of a jelly coat for normal in vitro fertilization methods).
This method has the beneﬁts of being less technically challenging
by eliminating manual oocyte defolliculation and reintroduction of
injected oocytes in the host female. In their surviving embryos
Miyamoto observed a similar striking mutation efﬁciency for the
tyrosinase and pax6 genes (between 80% and 90%) with all four
alloalleles being targeted. Both oocyte methods are highly efﬁcient
at inducing mutations early in development, and thus allow re-
searchers to study gene function in an F0 generation. This thereby
enables the rapid assessment of disease-causing gene mutations
without the need to establish mutant lines whilst also allowing
the study of those genes that are essential for embryo or sexual
maturation. In conclusion, these results show that TALENs work
efﬁciently in X. tropicalis and X. laevis, and that whilst home-
ologous X. laevis genes can be independently targeted with two
different pairs of TALENs, OHT is the most efﬁcient method to
generate mutations in all alloalleles in F0 animals.
3.3. CRISPR-Cas in Xenopus
Another genome editing technique that works well in Xenopus
is CRISPR-Cas, and it has become more widely used due to its
simpler design. In prokaryotes there are chromosomal loci that
Fig. 1. Genome editing using Xenopus embryos or oocytes. A comparison of the steps required to generate Xenopus mutants using either embryo injection or oocyte-host
transfer methods. (A) For the embryo injection method, TALEN mRNAs or Cas9 mRNA and/or protein along with sgRNA is microinjected into fertilized embryos at the one-
cell stage. The embryos are genotyped to conﬁrm editing efﬁciency using PCR-sequencing, T7 endonuclease assays, or high-resolution melt analysis. The F0 mosaic embryos
are allowed to develop, and gene function is analyzed using a host of established assays, including in situ hybridization (ISH) and immunohistochemistry (IHC). These
embryos, once grown to adulthood, can be tested for germline transmission to generate subsequent mutant lines. (B) An image of a mutant frog generated from embryos
injected at the one-cell stage with TALEN mRNAs targeting the tyrosinase gene shows mosaic pigmentation throughout the skin. (C) For the oocyte-host transfer method,
stage VI oocytes are surgically removed from an adult female frog, manually defollicated, and microinjected with TALENs or CRISPR-Cas9 capped mRNA and/or protein. The
oocytes are then matured using progesterone and colored with vital dyes for visualization; the coloring of oocytes is not necessary if implanted into an albino female. The
oocytes are then transferred into pre-primed host females and subsequently laid to incorporate the jelly coat that is essential for in vitro fertilization with sperm. The
resulting embryos are genotyped and phenotyped as previously described. (D) An image of a mutant frog generated from oocytes injected with the same TALENs as in panel
B, targeting the tyrosinase gene, shows more dramatic levels of albinism than the embryo-injected frog, thereby conﬁrming more efﬁcient mutagenesis.
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adjacent to these elements there are endonuclease gene coding
regions, termed CRISPR-associated genes (Cas) (Bolotin et al.,
2005; Jansen et al., 2002; Jinek et al., 2012; Makarova et al., 2015;
Wright et al., 2016). This combination provides the bacteria with
an acquired adaptive immune system capable of speciﬁcally tar-
geting nucleic acid sequences of invading viruses or plasmids
(Bhaya et al., 2011; Horvath and Barrangou, 2010; Karginov and
Hannon, 2010). Researchers have exploited the programmable
nature of this DNA targeting nuclease to mutate speciﬁc genetic
loci of interest in many model systems including Xenopus (Blitz
et al., 2013; Cho et al., 2013; Cong et al., 2013; Doudna and Char-
pentier, 2014; Guo et al., 2014; Harrison et al., 2014; Jinek et al.,
2012; Mali et al., 2013a; Nakayama et al., 2013; Peng et al., 2014).
To induce double strand breaks in Xenopus using CRISPR-Cas, one
or more single guide RNAs (sgRNA) targeting a gene of interest is
injected into Xenopus embryos together with the Cas en-
donuclease, either as mRNA or protein. This method is especially
time saving when targeting multiple loci in the same embryo,
because the sgRNAs can be generated by PCR in a single day, in
contrast to the multi-day process for cloning TALENs. However,
unlike TALENs, sgRNAs can only be designed to target regions
containing a protospacer adjacent motif (PAM) site, limiting the
regions that can be targeted.
Several recent reports in the past couple of years have shown
that CRISPR-Cas is highly efﬁcient in producing mutations in bothX. tropicalis and X. laevis (Blitz et al., 2013; Guo et al., 2014; Na-
kayama et al., 2013; Wang et al., 2015). Initial studies attempted to
optimize the amounts of sgRNA and Cas9 mRNA required to pro-
duce efﬁcient mutagenesis in the F0 generation with limited de-
velopmental defects. Generally, the amount of sgRNA required to
produce efﬁcient indels varies with each locus. For X. tropicalis,
most loci require a range of 50–200 pg sgRNA, whereas other loci
require up to 400 pg sgRNA; for X. laevis, 300–500 pg sgRNA is
optimal, but greater for some loci. Interestingly, the amount of
Cas9 mRNA required to induce indels varied among these studies.
Two of the studies revealed that a relatively high amount (2.2–
3 ng) of Cas9 mRNA is required to induce efﬁcient mutagenesis
(Blitz et al., 2013; Nakayama et al., 2013), whereas the third study
showed that a much lower amount (300–500 pg) is sufﬁcient (Guo
et al., 2014).
These reported Cas9 dosage discrepancies may be due to the
different Cas9 versions used in each study, which are identical at
the amino acid level, but are only 80% identical at the nucleotide
level (Cong et al., 2013; Mali et al., 2013b). As Xenopus codon usage
slightly differs from that of humans, the use of rare codons may
impact the translational efﬁciency of each Cas9 transcript, espe-
cially with the large size of the Cas9 protein. In addition, the two
versions differ at their N-and C-termini: the Cong Cas9, used by
the Chen lab, contains two nuclear localization sequences (NLS),
one at each end, and a 3X FLAG tag at the N-terminus, whereas the
Mali Cas9, used by Cho and Grainger labs, contains a single NLS at
P. Tandon et al. / Developmental Biology 426 (2017) 325–335330the C-terminus. Comparison of the codon usage showed that the
Cong Cas9 used slightly different codons, some of which were
more optimal for X. laevis. These differences may explain why a
lower dose of the Cong Cas9 was required in Xenopus. As both
versions were tested in the standard Xenopus vector, pCS2, they
contain identical 5′ and 3′UTRs. These initial reports illustrated
that CRISPR-Cas works efﬁciently in both X. laevis and X. tropicalis,
but that care must be taken in selecting codon-optimized tran-
scripts when performing mRNA injections of Cas9. An alternative
to Cas9 mRNA is to use Cas9 protein, which eliminates the con-
cerns of codon differences. The Khokha laboratory recently com-
pared the efﬁcacy of protein versus mRNA in Xenopus tropicalis
and found that Cas9 protein was more effective than mRNA
(Bhattacharya et al., 2015). They also reported Cas9 protein was
able to induce mutations earlier in development than Cas9 mRNA
and was less toxic. However, in light of the discussion of Cas9
codon usage, it is relevant to point out that they used Cas9 protein
from PNA Bio, which contains only one NLS.
In addition to the technical importance, the Khokha group's
study also clearly demonstrated that X. tropicalis can be used to
rapidly produce F0 phenotypes for human disease genes using
CRISPR-Cas. As we have discussed, many candidate genes for hu-
man diseases have been identiﬁed, but little functional analysis of
them has been possible, particularly outside a few model organ-
isms. In this study, they designed sgRNAs to six human disease
genes and showed that the F0 CRISPR mutants largely reproduced
the expected disease phenotypes. Thus, with the increased efﬁ-
ciency afforded by Cas9 protein injection, F0 analysis was sufﬁ-
cient for functional screening of candidate genes involved in hu-
man disease, expanding the utility of the X. tropicalis model for
this important application.
Beyond inducing genetic mutations, CRISPR-Cas can also be
used to label speciﬁc chromosomal regions (Chen et al., 2013) and
recent work by the Heald lab demonstrated how this can be ap-
plied to Xenopus (Lane et al., 2015). In this study they developed a
technique that allows for the creation of a library of sgRNAs tar-
geting a deﬁned genomic region, which they call CRISPR EATING
(everything available turned into new guides). The library is made
by PCR ampliﬁcation of speciﬁc genomic region followed by re-
striction digestion with an enzyme that cuts immediately 5′ to a
PAM sequence resulting in various sized fragments; subsequent
steps of adaptor ligations and restriction digests results in a mix-
ture of 136 nt sgRNA fragments that contain a T7 RNA polymerase
promoter for RNA transcription. The authors then complexed the
sgRNAs with a recombinant catalytically inactive Cas9 fused to
mNeon-Green (dCas9-Neon) to label speciﬁc chromosomal regions
using Xenopus sperm nuclei in vitro. One of the main beneﬁts of
this approach is the ability to use Xenopus egg extracts and sperm
nuclei to image genomic loci throughout the cell cycle. In addition
to being useful for visualization of genomic loci, this approach can
be adapted to generate mutations in larger regions of DNA that
will be of beneﬁt to making mutants in genes with many small
exons.
3.4. Knock-in strategies in Xenopus
Several different methods have been used for many years to
promote integration of exogenous DNA into the genome of Xeno-
pus laevis or Xenopus tropicalis for the production of transgenic
lines. These methods rely on random integration into the genome,
and as such will not be discussed here; we refer the reader to
several excellent reviews that cover these methods in detail (Allen
and Weeks, 2006; Chesneau et al., 2008; Love et al., 2011; Ogino
et al., 2006; Takagi et al., 2013; Yergeau et al., 2009). In contrast,
CRISPR-Cas and TALENs can be used for site-speciﬁc integration of
exogenous DNA and three recent reports demonstrated that thiscan be accomplished in Xenopus. In the ﬁrst study, they used TA-
LENs to create F0 knock-in X. laevis tadpoles through a micro-
homology-mediated end joining (MMEJ) strategy, which they refer
to as TALEN-mediated precise integration into target chromosome,
or TAL-PITCh (Nakade et al., 2014). They used a single homology
arm, containing the TALEN target site (with an inverted spacer
sequence) to insert exogenous DNA into two different loci, no29
and fgk (Fig. 2A). In the ﬁrst instance, they targeted the start codon
of no29 to knock-in a no29-GFP fusion template, whereas for fgk
they targeted the 3′ end to insert EGFP just before the stop codon
to make an endogenous fusion. In both instances, they found in-
tegration at the 5′ junction was precise in most cases, but at the 3′
junction there were often deletions and insertions. In the second
study, they used CRISPR-Cas to mediate integration of exogenous
DNA in X. tropicalis and showed efﬁcient germline transmission
(Shi et al., 2015). In contrast to traditional knock-in strategies that
use homology-dependent integration, this study showed that
targeted integration could be achieved independent of homology
arms, as long as the sgRNA target site is included in the donor DNA
(Fig. 2B). Although both methods showed that integration is im-
precise and results in deletions and insertions around the target
site, they illustrate that it is feasible to use TALENs and CRISPR-Cas
for insertional mutagenesis.
While knock-in of exogenous DNA in F0 embryos is mosaic, this
does not preclude all F0 studies as illustrated by a recent study by
the Mitchell lab (Jaffe et al., 2016). In that study, they used an
elegant knock-in approach to create mosaic mutant F0 X. laevis in
c21orf59, a gene involved in cilia polarization in multi-ciliated cells
(MCC) in Xenopus (Fig. 2C). As there are two c21orf59 alloalleles on
chromosomes 2L and 2S, the Mitchell lab developed a strategy that
allowed them to independently verify if one or both alloalleles
were mutated in individual cells. The injection of a single sgRNA to
target both gene homeologs was coupled with the incorporation of
two different donor vectors harboring either BFP or RFP reporter
genes. These vectors differed in their homology arm DNA sequence
that would target them speciﬁcally to either the Xla2L or Xla2S
alloallele. Using this approach, they identiﬁed those cells where
one or both alloalleles was disrupted. Cells that expressed both
BFP and RFP displayed a complete loss of cilia polarity, whereas
cells that expressed only BFP or RFP displayed an intermediate
phenotype. Such an approach takes good advantage of the differ-
ent alloalleles in Xenopus laevis and illustrates a useful general
method for knock-ins in Xenopus.4. Xenopus resources for genome editing (Xenbase and NXR)
Xenbase, the Xenopusmodel organism bioinformatics database,
is an invaluable resource for the design and application of reverse
genetics in Xenopus (James-Zorn et al., 2015). Xenbase (http://
www.xenbase.org) is a unique resource that serves as the central
repository for all things related to Xenopus genomics. It provides a
user-friendly interface to interrogate data related to a speciﬁc
gene, and in particular, it provides essential genomic sequences
and web-based tools for genome editing. Individual gene pages in
Xenbase provide a wealth of information for a particular gene,
including functional descriptions and expression proﬁles, asso-
ciations with human disease, and links to other model organism
databases. Individual gene pages also have information about the
genes in both X. tropicalis and X. laevis, including both L and S
homeologs in X. laevis. Each gene page provides a direct link to
GBrowse, which allows visualization of the gene structure (exons
and introns) and comparison of synteny with human and mouse
genomes to conﬁrm that the correct gene is being targeted. For an
unannotated gene, a BLAST search can be performed directly in
Xenbase to interrogate the respective genome and determine if the
Fig. 2. Integrating exogenous DNA into Xenopus using genetic editing tools. Outline of the various knock-in strategies that have been employed to insert DNA into a targeted
genomic locus in Xenopus. (A) Nakade et al. described the use of TALENs and microhomology-mediated end joining (MMEJ, TAL-PITCh) to integrate a ﬂuorescent protein (eg.
GFP) at the end of the coding region 5′ to the endogenous stop codon. (B) Shi et al. utilized CRISPR-Cas editing to insert plasmid DNA harboring a known pancreas tissue
enhancer element (Elastase promoter) driving GFP, into the intron of their target gene. (C) Jaffe et al., used targeting constructs containing allele-speciﬁc homology arms to
insert ﬂuorescent proteins into a sgRNA-targeted exon, thereby visualizing cells in which speciﬁc gene function was abrogated. TAA; stop codon, FokI; Fok1 nuclease, GFP;
green ﬂuorescent protein, pA; poly-A tail, sgRNA; guide RNA for CRISPR.
P. Tandon et al. / Developmental Biology 426 (2017) 325–335 331gene sequence is present. As annotation of the Xenopus genomes
continues to be updated, often times a gene may not appear as
annotated on the main gene page, but when viewed within
GBrowse, the exon and intron information is properly annotated.
Thus, it is critical to use the Xenbase BLAST function to identify the
chromosomal location of each gene. This information is extremely
useful when searching the X. laevis genome for both homeologs,
because Xenbase will identify both genes on the L and S chro-
mosomes. From GBrowse, one can then download the exon and
intron sequences for an individual gene. Xenbase also provides
useful links to several web-based genome editing tools for the
identiﬁcation of sgRNA or TALEN target sites. Thus, all of the in-
formation on Xenbase provides an essential platform to identify
chromosomal locations of genes, and to design sgRNA and TALEN
target sites.
Due to cost and space constraints, one of the difﬁculties within
the Xenopus community is the raising and breeding of speciﬁc
lines. In fact, most Xenopus laboratories are not experienced in
breeding and maintaining mutant lines, particularly with the di-
ploid X. tropicalis species that is ideal for genetic studies. For those
unable to generate or breed their own frog lines, the National
Xenopus Resource (NXR) offers a custom mutant service that will
design, inject, and breed F0 or F1 X. tropicalis or X. laevis frogs. The
NXR works closely with individual researchers to identify the
speciﬁc region of a gene that should be mutated, and they offer
multiple choices for genome editing, including TALEN and CRISPR
sgRNA design and injection. In addition, for those researchers
unable to maintain colonies of both X. laevis and X. tropicalis, or for
those wishing to work with multiple mutant lines, the NXR pro-
vides a unique service called research facility service, which allows
researchers to come to the NXR facility at the Marine Biological
Laboratory (MBL) for short-term visits. Here, they can access theresources at the NXR, including the large number of different X.
laevis and X. tropicalis strains and lines, and take advantage of the
genome editing expertise at the NXR. The NXR also provides a
service to raise and maintain animal lines at the MBL, thus al-
lowing researchers to enhance the scope of their research. Lastly, a
recent project funded by the NIH at the MBL is focused on creating
100–200 mutants for the Xenopus community; this new project
works with individual researchers to generate CRISPR-Cas- and
TALEN-mediated mutations in speciﬁc genes to create new Xeno-
pus models of human disease.5. Conclusions
There is substantial and growing evidence that TALENs and
CRISPR-Cas genome editing tools can now be used to manipulate
endogenous genes in both X. tropicalis and X. laevis, providing re-
searchers with the powerful ability to model a host of human
disorders. In Fig. 3, we outline the steps required to generate
mutants in Xenopus using TALENs or CRISPR-Cas systems; how-
ever, a more detailed discussion of CRISPR-Cas protocols in Xeno-
pus can be found in a recent review (Nakayama et al., 2014). The
design and application of genome editing tools for Xenopus has
been streamlined by incorporating online software to design tar-
get oligonucleotides and assess potential off-target effects in the
Xenopus genome. These tools, combined with simple DNA ex-
traction and PCR techniques that are already employed by most
laboratories, will enable the generation and identiﬁcation of mu-
tant embryos in a fast and efﬁcient manner, allowing the estab-
lishment of mutant lines (Fig. 3). TALENs and CRISPR-Cas can be
used in a variety of ways in Xenopus to modify speciﬁc protein
domains, rearrange chromosomal organization, or to introduce the
Fig. 3. Workﬂow for generating Xenopusmutants using TALENs and CRISPR-Cas9. A schematic depicts the steps required to generate the gene editing tools to target a gene of
interest, induce mutations in Xenopus embryos, perform subsequent assays to phenotype mosaic F0 embryos, and generate mutant lines. For more detailed information
including web URLs we refer the reader to Xenbase (http://www.xenbase.org/other/static/CRISPr.jsp).
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wide association studies (GWAS). In addition, unbiased studies of
organ formation and function in Xenopus have been shown to
reveal phenotypes similar to those observed in human diseases
(Iwasaki and Thomsen, 2014; Pearl et al., 2011; Sojka et al., 2014);
thus, the generation of new mutants via genome editing may lead
to the identiﬁcation of new disease candidates. Therefore, the
genome-edited Xenopus model will be instrumental as an initial
tool for understanding the components and pathways affected by
genetic disorders in a highly conserved vertebrate in vivo en-
vironment, which is not yet achievable with primary cell cultures
or mammalian models. Furthermore, when coupled with high-
throughput assays that require tissue explants and/or large num-
bers of embryonic samples, the genome-edited Xenopus model
should aid the discovery of chemical or gene therapeutics that may
serve to treat human diseases.Funding
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